CTLA4 and neoplasm: RT also potentiated the clinical efficacy of CTLA-4 blockades by enhancing T cell recruitment and infiltration of the tumour bed, stabilising NKG2D engagement with Rae-1 and increasing TCR clonality within the TME [137,138,139,140].